CGON CG Oncology Inc Net Assets per Single Share

Graphic logo of CG Oncology Inc (CGON)

The business specifics of CG Oncology, Inc. (CGON) rely on strict temperature-controlled transport of components, which increases costs. Financial stability following the IPO allows the company to control research expenses for bladder therapy, where the indicator stands at 11.63. This price action chart on GURU.Markets demonstrates the quote movement of the company, which is developing bioengineering for oncolytic viruses and possesses colossal scientific potential in immunotherapy.

CGON (CG Oncology Inc) Accounting Value per Share history from 02/21/2024 to 10/29/2026

Financial and market metric breakdowns for cgoncology.com (CGON)

- current quotes and average value forecast:
Price Chart CG Oncology Corp|CGON - Average Forecast Price
- market capitalization data:
Market Value CG Oncology, Inc.|CGON - Business Value
- shareholders' equity book value data:
Book Value per Share CG Oncology|CGON - Company Net Assets|Market Capitalization to Book Value Ratio cgoncology.com|CGON - Company Total Assets
- debt burden and liquidity indicators:
Debt to Equity CG Oncology, Inc.|CGON - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital CG Oncology|CGON - Company Total Debt|Debts to Book Capitalization CG Oncology, Inc.|CGON - Long-Term Debt|Company Short-Term Debt CG Oncology|Quick Liquidity Indicator cgoncology.com
- net income and valuation multiples indicators:
CGON - Final Profit
Initial company analysis:CG Oncology Corp (CGON)
Mass-produced product of cgoncology.com

CG Oncology, Inc. (CGON) is focusing its resources on completing clinical trials through strategic partnerships. The book value per share trend reflects capital management efficiency without relying on external acquisitions. This metric is calculated as the difference between total assets and liabilities, divided by the number of shares outstanding. It demonstrates the real value of an investor's stake net of debt. Analysis of this chart allows for an assessment of the company's asset base stability.

Main competitors

ONC - Net Assets per Single Share|Net Asset Value per Share Halozyme Corp|Revolution Medicines (RVMD) - Net Assets per Single Share|Equity per Share AAPG|URGN (UroGen Pharma) - Book Value per Share|Accounting Value per Share Bicara Therapeutics Inc (BCAX)|Book Value per Share PSNL|Book Value per Share Erasca Oncology (ERAS)|Net Assets per Single Share Delcath Systems, Inc. DCTH|YMAB: Equity per Share|Aura Biosciences - Book Value per Share|Candel Therapeutics (CADL) - Accounting Value per Share|ARAY: Book Value per Share|Net Asset Value per Share SELLAS Life Sciences Group (SLS)|Net Assets per Single Share Actuate Therapeutics, Inc.|CTOR: Accounting Value of a Share|Accounting Value per Share HURA (TuHURA Biosciences, Inc.)|TARA (Protara Therapeutics Inc) - Accounting Value of a Share|Book Value per Share FATE (Fate Therapeutics Corp)|WHWK - Accounting Value per Share|TCRX: Accounting Value per Share|CSBR - Book Value per Share|xbiotech.com (XBIT) - Net Assets per Single Share|CEL-SCI - Accounting Value of a Share|OSTX (OS Therapies Inc) - Book Value per Share|Net Asset Value per Share radiopharmtheranostics.com RADX|Book Value per Share ARTV|Accounting Value per Share adlainortye.com ANL|Book Value per Share VERU (Veru)|Book Value of One Share Tempest Therapeutics Inc|XLO: Accounting Value per Share|Accounting Value of a Share RENB (Renovaro Inc.)|muraloncology.com (MURA) - Net Assets per Single Share|Net Asset Value per Share Kairos Pharma (KAPA)|Net Assets per Single Share OnKure Therapeutics, Inc.|Equity per Share GDTC (CytoMed)|Book Value per Share CRIS|Accounting Value per Share apollomicsinc.com APLM|Net Assets per Single Share Tharimmune, Inc. THAR|Advanced Biomed Inc. (ADVB) - Net Asset Value per Share|GNPX - Net Assets per Single Share|CLDI: Net Assets per Single Share|Sunshine Biopharma, Inc. (SBFM) - Net Assets per Single Share|Net Asset Value per Share Xenetic Biosciences, Inc. (XBIO)|SLRX (Salarius Pharmaceuticals) - Book Value per Share|PPBT - Book Value of One Share|Accounting Value per Share AONC (American Oncology Network)|BGNE - Net Asset Value per Share|Checkpoint Therapeutics, Inc - Accounting Value per Share|Accounting Value of a Share ELEV|iCAD Corp - Book Value per Share|Net Assets per Share Ikena Oncology, Inc. IKNA|Notable Labs (NTBL) - Net Assets per Single Share|Equity per Share VIRX|MOR (MorphoSys Corp) - Book Value per Share|Accounting Value per Share NAYA Biosciences Corp (NAYA)|Accounting Value per Share AAPGV (Ascentage Pharma Group)